CVKD — Cadrenal Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $27.90m
- $22.33m
Annual cashflow statement for Cadrenal Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -6.71 | -8.36 | -10.7 |
| Depreciation | |||
| Non-Cash Items | 4.9 | 4.68 | 1.42 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.608 | 0.144 | 1.87 |
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Net Change in Other Assets & Liabilities | |||
| Cash from Operating Activities | -1.2 | -3.53 | -7.36 |
| Other Investing Cash Flow Items | -0.002 | -0.003 | -0.007 |
| Purchase of Investments | |||
| Cash from Investing Activities | -0.002 | -0.003 | -0.007 |
| Financing Cash Flow Items | — | — | -0.338 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 1.24 | 11.9 | 8.98 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0.033 | 8.37 | 1.62 |